A new study is intensifying the debate over how generative artificial intelligence (genAI) systems use creative content, warning that current consent mechanisms are fundamentally flawed. The research ...

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, ...

What does the future hold for sign language and artificial intelligence? No one knows for sure, but at the inaugural SLxAI ...

From Jen Liu’s pounds of flesh to Josh Kline’s viral essay, the feeling that something is irreversibly decomposing is rife ...

Michael C. Gray has been working with stock option taxation since the start of the Silicon Valley tech boom. I spoke with him to get his insights into the tax complexity.

Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...

A 2026 informational overview of ProvaDent's oral probiotic formulation, BioFresh™ enzyme complex, dental sugar hack ...

Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Pro Football and Sports Network: Drew Allar is perhaps the most quintessential “prototypical QB” in the 2026 NFL Draft. A ...

Net Loss: The net loss attributable to Serina common stockholders for the year ended December 31, 2025 was $19.4 million, or $ (1.91) per basic and diluted share, compared to net loss of $11.1 million ...

Informing financial consumers about emerging trends and companies making an impact in the industry, Jon is most knowledgeable in the areas of budgeting, credit card rewards, and responsible credit use ...

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript March 31, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2025 ...